273 related articles for article (PubMed ID: 11686478)
1. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
[TBL] [Abstract][Full Text] [Related]
2. Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma).
Soe K; Hishikawa Y; Fukuzawa Y; Win N; Yin KS; Win KM; Myint AA; Koji T
J Gastroenterol; 2007 Mar; 42(3):225-35. PubMed ID: 17380281
[TBL] [Abstract][Full Text] [Related]
3. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
4. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
[TBL] [Abstract][Full Text] [Related]
6. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
8. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
[TBL] [Abstract][Full Text] [Related]
9. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
Shen HW; Gao SL; Wu YL; Peng SY
World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Fas ligand on peritumoral lymphocytes and its association with apoptosis of colorectal carcinomas].
Song E; Chen J; Wang J; Zhang L
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):517-9, 29. PubMed ID: 11832097
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
[TBL] [Abstract][Full Text] [Related]
13. The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma.
Kubo K; Matsuzaki Y; Okazaki M; Kato A; Kobayashi N; Okita K
Liver; 1998 Apr; 18(2):117-23. PubMed ID: 9588770
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Fas and Fas ligand in infiltrating lymphocytes in patients with oral lichen planus].
Lei L; Tan WX; Zhou XL; Zheng PE
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Apr; 45(4):219-22. PubMed ID: 20654197
[TBL] [Abstract][Full Text] [Related]
15. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
16. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
[TBL] [Abstract][Full Text] [Related]
17. Expression of fas ligand on bile ductule epithelium in biliary atresia--a poor prognostic factor.
Liu C; Chiu JH; Chin T; Wang LS; Li AF; Chow KC; Wei C
J Pediatr Surg; 2000 Nov; 35(11):1591-6. PubMed ID: 11083430
[TBL] [Abstract][Full Text] [Related]
18. Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma.
Xu LN; Zou SQ; Wang JM
World J Gastroenterol; 2005 Jun; 11(24):3719-23. PubMed ID: 15968727
[TBL] [Abstract][Full Text] [Related]
19. [Perforin and Fas-ligand expression of tumor infiltrating lymphocytes in human hepatocellular carcinoma].
Qian Q; Wu M; Qu Z
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):99-101. PubMed ID: 11244971
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.
Peng Z; Tang H; Ling Y; Han G
J Tongji Med Univ; 2001; 21(2):126-9, 148. PubMed ID: 11523216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]